Buck, Neil Robert,Stoecklin, Elisabeth,Leuenberger, Bruno H.,Wolfram, Swen,Urban, Kai,Claerhout, Wouter
申请号：
AU2009214053
公开号：
AU2009214053B2
申请日:
2009.02.12
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
We disclose treating hyperglycemia in a human with 25-hydroxyvitamin D3 (calcifediol). Blood glucose is reduced to a level which is closer to normal than baseline. Vitamin D3 (cholecalciferol) may optionally be used together with 25-hydroxy vitamin D3. Forms and dosages of a pharmaceutical composition, as well as processes for manufacturing medicaments, are also disclosed.
